Table 3: Characteristics of background therapy in patients with sJIA at the moment of enrollment in the study.

DrugDose (median (25; 75))Number of children

Methotrexate, mg/m2/week19 (15; 24)17
Prednisolone, mg/day +8.7 (6.3; 12)
Methotrexate, mg/m2/week 19 (15;23)11
Methotrexate, mg/m2/week +17 (15; 23)
Cyclosporine, mg/kg/day4 (4; 4)14
Prednisolone, mg/day +9.5 (6.5; 12)
Methotrexate, mg/m2/week +17 (15; 23)
Cyclosporine, mg/kg/day4 (4; 4)33
NSAIDs75